Atlas Trials

The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years

Clinical trial NCT05179733 · UNKNOWN

Trial details

NCT number
NCT05179733
Sponsor
Ruijin Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Diffuse Large B-Cell Lymphoma
Start date
2022-03-02
Primary completion
2025-12-25
Enrollment
280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.